Annotated Medicine and Device Lists

Irinotecan

Injection 100mg/10g Injection 40 mg/ 2 ml in 2 ml vial Injection 100 mg/ 5 ml in 5 ml vial Injection 500 mg/ 25 ml in 25 ml vial Injection 2 mg/mL x 5 mL Injection 100 mg/ ml Injection 2 mg/mL x 2 mL Injection 100 mg/ 5 ml N/A Solution for injection 20 mg/ mL

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Mexico. Cuadro Basico de Medicamentos - 2017	17. ONCOLOGIA	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	No observations
Haiti. National List of Essential Medicines	08.02 Cytotoxic and adjuvant drugs	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	No observations
Haiti. National List of Essential Medicines	08.02 Cytotoxic and adjuvant drugs	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	8.2.1 Cytotoxic medicines	No observations
Haiti. National List of Essential Medicines	08.02 Cytotoxic and adjuvant drugs	No observations

This medicine is present in:

List	Section	Observation
Cayman Islands Health Services Authority Pharmacy Drug Formulary	Topoisomerase I Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	10. ANTINEOPLASTIC AND RELATED AGENTS	No observations

This medicine is present in:

List	Section	Observation
Cayman Islands Health Services Authority Pharmacy Drug Formulary	Topoisomerase I Inhibitors	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Miscellaneous Agents	No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.	CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.	Others observations: CLORHIDRATO. Bulbo
Mexico. Cuadro Basico de Medicamentos - 2017	17. ONCOLOGIA	No observations

This medicine is present in:

List	Section	Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	18.01. FÁRMACOS CITOTÓXICOS	No observations

This medicine is present in:

List	Section	Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019	41. Antineoplásicos y agentes inmunomoduladores	No observations
Bahamas. Drug Formulary	10. ANTINEOPLASTIC AND RELATED AGENTS	No observations

Information Resources: Irinotecan

No information available